Sign In
Buy IRTC
$104.56
-0.94 (-0.89%)
At Close: Jun 03, 2026
iRhythm resumed with an Equal Weight at Wells Fargo
05:44am, Tuesday, 03'rd Dec 2024
Wells Fargo analyst Nathan Treybeck resumed coverage of iRhythm with an Equal Weight rating and $86 price target. The analyst believes stock upside will be limited until there is greater certainty on
iRhythm Technologies to Participate in the Citi 2024 Global Healthcare Conference
04:30pm, Wednesday, 20'th Nov 2024
SAN FRANCISCO, Nov. 20, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and preven
Five new studies span three focus areas for LTCM devices: digital engagement and patient satisfaction, arrhythmia patterns during sleep and activity, and the potential health care resource and economi
iRhythm Technologies to Participate in the Wolfe Research 2024 Healthcare Conference
04:30pm, Tuesday, 05'th Nov 2024
SAN FRANCISCO, Nov. 05, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and preven
NEW YORK, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against iRhythm Technologies, Inc. (NASD
iRhythm Technologies, Inc. (IRTC) Q3 2024 Earnings Call Transcript
08:26pm, Wednesday, 30'th Oct 2024
iRhythm Technologies, Inc. (NASDAQ:IRTC ) Q3 2024 Results Conference Call October 30, 2024 4:30 PM ET Company Participants Stephanie Zhadkevich - Director, Investor Relations Quentin Blackford - Presi
IRhythm Technologies (IRTC) Reports Q3 Loss, Tops Revenue Estimates
07:36pm, Wednesday, 30'th Oct 2024
IRhythm Technologies (IRTC) came out with a quarterly loss of $1.26 per share versus the Zacks Consensus Estimate of a loss of $0.55. This compares to loss of $0.89 per share a year ago.
iRhythm Technologies Receives FDA 510(k) Clearance for Design Modifications to Its Zio® AT Device
05:15pm, Wednesday, 30'th Oct 2024
Zio AT device, along with the Zio ECG Utilization Software (ZEUS) (K222389), enables the provision of ambulatory Mobile Cardiac Telemetry (MCT) monitoring service for non-critical care patients
iRhythm Technologies Announces Third Quarter 2024 Financial Results
04:08pm, Wednesday, 30'th Oct 2024
SAN FRANCISCO, Oct. 30, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prev
SAN FRANCISCO, Oct. 28, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health company focused on creating trusted solutions that detect, predict, and prevent dise
iRhythm Technologies (IRTC) Soars 21.7%: Is Further Upside Left in the Stock?
08:50am, Wednesday, 23'rd Oct 2024
iRhythm Technologies (IRTC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength
With FDA Approval iRhythm May Be Able To Lift Regulatory Overhang, Investor Skepticism, Analyst Says
01:18pm, Tuesday, 22'nd Oct 2024
On Monday, the FDA approved iRhythm Technologies, Inc.'s IRTC 510(k) submission related to prior design changes to the Zio AT device via letter to file.
iRhythm Technologies Stock Rises Post FDA Clearance for Zio AT
12:41pm, Tuesday, 22'nd Oct 2024
IRTC receives FDA 510(k) clearance for prior design modifications to its Zio AT device, reinforcing its commitment to quality and compliance.
iRhythm Technologies Receives FDA 510(k) Clearance for Design Updates Previously Made to Its Zio® AT Device
04:05pm, Monday, 21'st Oct 2024
Zio AT device, along with the Zio ECG Utilization Software (ZEUS) (K222389), enables the provision of ambulatory Mobile Cardiac Telemetry (MCT) monitoring service for non-critical care patients Zio AT
iRhythm Technologies to Report Third Quarter 2024 Financial Results on October 30, 2024
04:05pm, Wednesday, 16'th Oct 2024
SAN FRANCISCO, Oct. 16, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict
